Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Burrows

Showing results (51-60 of 139) with videos related to

Pageof 14
Sort By:
Plos One|March 3, 2012
P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-actionLaura M Sanz, Benigno Crespo, Cristina De-Cózar, et al.
Journal of Vector Borne Diseases|May 10, 2019
Partnering to fight malaria in India: Past, present and futureKirandeep Samby, Hanu Ramachandruni, Jaya Banerji, et al.
Malaria Journal|June 3, 2014
Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparumVicky M Avery, Sridevi Bashyam, Jeremy N Burrows, et al.
Physical Review. E|March 17, 2017
Quantitative shadowgraphy and proton radiography for large intensity modulationsMuhammad Firmansyah Kasim, Luke Ceurvorst, Naren Ratan, et al.
Journal of Medicinal Chemistry|May 8, 2014
Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitorsXiaoyi Deng, Sreekanth Kokkonda, Farah El Mazouni, et al.
Nature Reviews. Drug Discovery|October 6, 2015
Hit and lead criteria in drug discovery for infectious diseases of the developing worldKei Katsuno, Jeremy N Burrows, Ken Duncan, et al.
Malaria Journal|January 15, 2017
New developments in anti-malarial target candidate and product profilesJeremy N Burrows, Stephan Duparc, Winston E Gutteridge, et al.
Malaria Journal|April 20, 2017
Erratum to: New developments in anti-malarial target candidate and product profilesJeremy N Burrows, Stephan Duparc, Winston E Gutteridge, et al.
Journal of Cheminformatics|June 3, 2024
Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparumReagan M Mogire, Silviane A Miruka, Dennis W Juma, et al.
Clinical and Experimental Immunology|November 21, 1997
Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory diseaseJ D Isaacs, N Burrows, M Wing, et al.
Pageof 14

Showing results (51-60 of 139) with videos related to

Sort By:
Pageof 14
Plos One|March 3, 2012
P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-actionLaura M Sanz, Benigno Crespo, Cristina De-Cózar, et al.
Journal of Vector Borne Diseases|May 10, 2019
Partnering to fight malaria in India: Past, present and futureKirandeep Samby, Hanu Ramachandruni, Jaya Banerji, et al.
Malaria Journal|June 3, 2014
Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparumVicky M Avery, Sridevi Bashyam, Jeremy N Burrows, et al.
Physical Review. E|March 17, 2017
Quantitative shadowgraphy and proton radiography for large intensity modulationsMuhammad Firmansyah Kasim, Luke Ceurvorst, Naren Ratan, et al.
Journal of Medicinal Chemistry|May 8, 2014
Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitorsXiaoyi Deng, Sreekanth Kokkonda, Farah El Mazouni, et al.
Nature Reviews. Drug Discovery|October 6, 2015
Hit and lead criteria in drug discovery for infectious diseases of the developing worldKei Katsuno, Jeremy N Burrows, Ken Duncan, et al.
Malaria Journal|January 15, 2017
New developments in anti-malarial target candidate and product profilesJeremy N Burrows, Stephan Duparc, Winston E Gutteridge, et al.
Malaria Journal|April 20, 2017
Erratum to: New developments in anti-malarial target candidate and product profilesJeremy N Burrows, Stephan Duparc, Winston E Gutteridge, et al.
Journal of Cheminformatics|June 3, 2024
Protein target similarity is positive predictor of in vitro antipathogenic activity: a drug repurposing strategy for Plasmodium falciparumReagan M Mogire, Silviane A Miruka, Dennis W Juma, et al.
Clinical and Experimental Immunology|November 21, 1997
Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory diseaseJ D Isaacs, N Burrows, M Wing, et al.
Pageof 14